Effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on respiratory burst activity of neutrophiis in patients with myelodysplastic syndromes
Open Access
- 1 February 1993
- journal article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 91 (2) , 308-313
- https://doi.org/10.1111/j.1365-2249.1993.tb05900.x
Abstract
The superoxide (O2‐releasing capacity in response lo N‐fomiyl‐methionyl‐leucyl‐phenylalanine (FMLP)and the priming effects ofrecombinant human granuloeyte colony‐stimulating factor (rhG‐CSF) and granulocyte‐macrophage colony‐stimulating faclor (rhGM‐CSF) on FMLP‐induced O2 release were investigated in neutrophils from 14 patients with myelodysplastic syndromes (MDS). The O2 ‐releasing capacity in MDS neutrophils varied from patient to patient. As compared with normal neutJ‐ophils. theO2‐releasing capacity in MDS neutrophils was increased in 9/14 patients, nonnal in three patients and decreased in two patients. There was no close relationship between the 02‐reIeasing capacity and the peripheral blood neutrophil count or the plasma concentration of C‐reactive protein. The priming of neutrophils by rhG‐CSF was not observed in five patients, whereas rhGM‐CSF primed neutrophils from all patients. The priming eflect of rhGM‐CSF was consistently greater than that of rhG‐CSF in each patient. The intravenous administration of rhG‐CSF (300 μg/body) to two MDS patients showed an increase in the peripheral blood neutrophil count and enhancement of neutrophil O2 release. These findings demonstrate that the neutrophil O2‐releasing capacity in MDS varies from patient to patient and is not always impaired, and that rhGM‐CSF is able to prime neutrophils which never respond to rhG‐CSF.Keywords
This publication has 31 references indexed in Scilit:
- Superoxide anion production and expression of cytochrome b 558 by neutrophils are impaired in some patients with myelodysplastic syndromeAnnals of Hematology, 1991
- Stimulation and priming of human neutrophils by granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: Qualitative and quantitative differencesBiochemical and Biophysical Research Communications, 1990
- Treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor: A preliminary reportThe American Journal of Medicine, 1989
- Phorbol myristate acetate potentiates superoxide release and membrane depolarization without affecting an increase in cytoplasmic free calcium in human granulocytes stimulated by the chemotactic peptide, lectins and the calcium ionophoreBiochimica et Biophysica Acta (BBA) - Biomembranes, 1988
- Effects of Recombinant Human Granulocyte–Macrophage Colony-Stimulating Factor in Patients with Myelodysplastic SyndromesNew England Journal of Medicine, 1987
- Recombinant human granulocyte colony-stimulating factor enhances superoxide release in human granulocytes stimulated by the chemotactic peptideBiochemical and Biophysical Research Communications, 1987
- Recombinant Human Granulocyte Colony-Stimulating Factor: Effects on Normal and Leukemic Myeloid CellsScience, 1986
- Human GM-CSF: Molecular Cloning of the Complementary DNA and Purification of the Natural and Recombinant ProteinsScience, 1985
- Human granulocyte-macrophage colony-stimulating factor is a neutrophil activatorNature, 1985
- Defective neutrophil function and microbicidal mechanisms in the myelodysplastic disorders.Journal of Clinical Pathology, 1983